Results 61 to 70 of about 976,634 (303)
Boxplot: Spleen diameter and platelet count subgroups.
Boxplot: Spleen diameter and platelet count subgroups.
Frank Lammert (2875) +3 more
core +1 more source
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
Boxplot: IPF% and the platelet count subgroups.
Boxplot: IPF% and the platelet count subgroups.
Frank Lammert (2875) +3 more
core +1 more source
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
Platelet count in men with a habit of alcohol drinking
Alcohol inhibits platelet function, and platelet count is often reduced in individuals with alcohol use disorder. However, the relation of habitual alcohol drinking with platelet count in a general population remains to be determined.
Ichiro Wakabayashi
doaj +1 more source
The GGB numbers counted on SWI images were significantly correlated with the portal vein diameter (a), SI (b), platelet count (PC) (c), and platelet count/spleen diameter ratio (d).
Yi Fan (285912) +7 more
core +1 more source
PANoptosis in the pathogenesis of myelodysplastic syndromes
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla +4 more
wiley +1 more source
Background Oral thrombopoietin receptor agonists are used to treat thrombocytopenia in patients with chronic liver disease who are scheduled for invasive procedures. The efficacy of lusutrombopag based on the pretreatment platelet count was investigated.
Takayoshi Suga +13 more
doaj +1 more source
(B) Trend of CD4 count, haemoglobin, platelet count and absolute neutrophil count, September 2012-August 2013.
Nicholas J. Gow (787295) +4 more
core +1 more source

